Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

TP Icap Q1 revenues down against strong comparator

Wed, 15th May 2024 09:24

(Sharecast News) - Financial services firm TP ICAP said on Wednesday that revenues were down year-on-year in the three months ended 31 March against a strong Q123 performance.

TP ICAP said total group revenues were down 3% in Q1 at £570.0m but said its April performance was "very strong" and, as a result, total revenue for the first four months was up 3%.

The FTSE 250-listed group also noted that it "remains comfortable" with current market expectations for FY24, subject to movements in foreign exchange rates.

In global broking, following near-record revenue in March 2023, Q1 revenue declined by 7%, while energy and commodities revenue was up 8% with the division benefitting from "buoyant market conditions".

TP ICAP added that Parameta Solutions saw revenues grow by 12%, driven by ongoing demand, new clients, and a focus on direct distribution. At Liquidnet, its cash equities business, revenues grew by 7%, building on the momentum established in the latter part of 2023.

As of 0920 BST, TP ICAP shares were down 1.76% at 219.08p.

Reporting by Iain Gilbert at Sharecast.com

Related Shares

More News
17 May 2024 15:43

UK dividends calendar - next 7 days

8 May 2024 15:55

UK shareholder meetings calendar - next 7 days

8 May 2024 15:52

UK earnings, trading statements calendar - next 7 days

2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.